Ministerio de Industria, Turismo y Comercio LogoMinisterior
 

Alerta

Resultados 152 resultados
LastUpdate Última actualización 17/09/2025 [07:07:00]
pdfxls
Solicitudes publicadas en los últimos 60 días / Applications published in the last 60 days
previousPage Resultados 100 a 125 de 152 nextPage  

SENSOR, SYSTEM AND METHOD FOR NON-INVASIVE BLOOD ANALYSIS

NºPublicación:  US2025241561A1 31/07/2025
Solicitante: 
IMAM ABDULRAHMAN BIN FAISAL UNIV [SA]
Imam Abdulrahman Bin Faisal University
US_2023190143_PA

Resumen de: US2025241561A1

A non-invasive glucose sensor used for glucose detection in a subject is provided. The sensor includes a long channel source to excite a first location of a skin and a long channel detector to detect near infrared (NIR) energy emitted from the first location of the skin. A short channel source excites a second location of the skin and a short channel detector detects NIR energy emitted from the second location of the skin. The sensor further includes a long channel processor to process a long channel electrical signal into a glucose spectroscopic data and a short channel processor to process a short channel electrical signal into a background spectroscopic data. The sensor includes a spectroscopic processor to subtract the background spectroscopic data from the glucose spectroscopic data, and thereby to produce data indicative of a quantity of glucose present in the subject's blood.

Time averaged basal rate optimizer

NºPublicación:  AU2025205479A1 31/07/2025
Solicitante: 
DEXCOM INC
Dexcom, Inc
AU_2025205479_A1

Resumen de: AU2025205479A1

Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated. Systems and methods for integrating a continuous glucose sensor 12, including a receiver 14, a medicament delivery device 16, a controller module, and optionally a single point glucose monitor 18 are provided. Integration may be manual, semi-automated and/or fully automated. ul y s t e m s a n d m e t h o d s f o r i n t e g r a t i n g a c o n t i n u o u s g l u c o s e s e n s o r , i n c l u d i n g a u l r e c e i v e r , a m e d i c a m e n t d e l i v e r y d e v i c e , a c o n t r o l l e r m o d u l e , a n d o p t i o n a l l y a s i n g l e p o i n t g l u c o s e m o n i t o r a r e p r o v i d e d n t e g r a t i o n m a y b e m a n u a l , s e m i - a u t o m a t e d a n d o r f u l l y a u t o m a t e d

Conception et Développement d'un Smart Glucomètre non invasif à longue durée de vie

NºPublicación:  MA63555A1 31/07/2025
Solicitante: 
FONDATION DE RECH DE DEVELOPPEMENT ET DINNOVATION EN SCIENCES ET INGENIERIE [MA]
LC2A [MA]
Fondation de Recherche de D\u00E9veloppement et d'Innovation en Sciences et Ing\u00E9nierie,
LC2A
MA_63555_A1

Resumen de: MA63555A1

The present invention highlights a non-invasive, long-lasting smart glucometer that falls within the field of the medical biotechnology industry. An innovative smart solution is proposed, involving the use of a long-life sensor glucose meter with a distributed system to deliver treatments. The central idea is to enable continuous, non-invasive monitoring of blood glucose, thus eliminating the need for repeated injections. This approach aims to improve the quality of life of diabetes patients by offering more convenient, real-time monitoring.

METHOD AND DEVICE FOR PREDICTING RISK OF GESTATIONAL DIABETES BY USING ARTIFICIAL INTELLIGENCE MODEL

NºPublicación:  WO2025159222A1 31/07/2025
Solicitante: 
SUNGKWANG MEDICAL FOUND [KR]
\uC758\uB8CC\uBC95\uC778 \uC131\uAD11\uC758\uB8CC\uC7AC\uB2E8
WO_2025159222_PA

Resumen de: WO2025159222A1

The present disclosure relates to a method and a device for predicting the risk of gestational diabetes by using an artificial intelligence model. An embodiment of the present disclosure may provide a method for predicting the risk of gestational diabetes by using an artificial intelligence model, the method comprising the steps of: inputting data on a mother to a gestational diabetes prediction model generated on the basis of a training data set; and obtaining the incidence rate of gestational diabetes from the gestational diabetes prediction model, wherein the data on the mother includes a final variable determined from multiple initial variables of the training data set.

APPARATUS FOR GLYCEMIC CONTROL

NºPublicación:  US2025246285A1 31/07/2025
Solicitante: 
INSULET CORP [US]
INSULET CORPORATION

Resumen de: US2025246285A1

Techniques, systems and devices for glycemic control are presented. An apparatus may include a display device and a processor in electronic communication with the display device. The apparatus includes a memory communicatively connected to the processor. The memory includes instructions configuring the processor to generate a user interface through the display device and receive user input through the user interface. The processor is configured to implement an activity mode of a plurality of activity modes of a wearable medical device based on the user input. The activity mode is indicative of temporary conditions affecting blood glucose levels of the user. The processor is configured to receive biological data from a user through a biological sensor in communication with the processor and calculate an amount of medication to deliver to a user based on the biological data and the implemented activity mode.

SENSING SYSTEMS AND METHODS FOR HYBRID GLUCOSE AND KETONE MONITORING

NºPublicación:  AU2023415722A1 31/07/2025
Solicitante: 
DEXCOM INC
DEXCOM, INC
AU_2023415722_PA

Resumen de: AU2023415722A1

Certain aspects of the present disclosure relate to a monitoring system comprising a continuous analyte sensor configured to generate analyte measurements associated with analyte levels of a patient, and a sensor electronics module coupled to the continuous analyte sensor and configured to receive and process the analyte measurements.

GLUCOSE SENSOR FOR GLYCEMIC ASSESSMENT

NºPublicación:  WO2025160068A1 31/07/2025
Solicitante: 
ABBOTT DIABETES CARE INC [US]
ABBOTT DIABETES CARE INC
WO_2025160068_PA

Resumen de: WO2025160068A1

An analyte assessment system includes an analyte sensor, a remote device, and a software application. The remote device is configured to retrieve sensor data of a patient from the analyte sensor. The software application is configured to receive an order for analyte assessment associated with an electronic medical record (EMR) of the patient, generate or retrieve a unique identifier associated with the order, authenticate the unique identifier with the remote device, activate the analyte sensor based on the unique identifier, retrieve sensor data from the remote device, generate a report, and upload the report to the EMR of the patient. Advantageously the system can streamline requests and delivery of analyte reports for third parties, reduce in-person patient interactions and time delays, reduce third party effort, increase security and integrity of patient data, update an EMR of the patient, and operate in a blinded mode for unbiased patient analyte assessment.

A BOTULINUM TOXIN SYRINGE

NºPublicación:  ZA202409280B 30/07/2025
Solicitante: 
WEBB THOMAS [AU]
WEBB, Thomas
JP_2025519541_PA

Resumen de: ZA202409280B

A botulinum toxin syringe having a barrel has volumetric marking graduations scaled at four units per 0.1 mL. These volumetric marking graduations allow for ease of unit conversion and can reduce the likelihood of overdosing or under dosing of botulinum toxin. The syringe may further comprise further volumetric marking graduations configured to be interchangeably used for administration of insulin or botulinum toxin. The syringe may further comprise further volumetric marking graduations configured for interchangeably use for administration of different types of botulinum toxin.

CONTINUOUS GLUCOSE MONITORING DEVICE

NºPublicación:  EP4592427A2 30/07/2025
Solicitante: 
ALLEZ HEALTH INC [US]
Allez Health Inc
EP_4592427_A2

Resumen de: EP4592427A2

An apparatus includes a body and an actuator is coupled to the body. A needle is mounted to the actuator. The needle comprises a slot along a length to a tip. A sensor is coupled to a plurality of wires. A base is configured to be moveable by the actuator and includes a cutout, a circuit board having a microprocessor, and a plurality of contacts. Each contact is coupled to a wire of the plurality of wires. A power source is connected to the circuit board and to the base. A bracket is coupled to the bottom surface of the body and configured to receive the base. A patch is coupled to the bracket and has an adhesive. A needle is configured to be moveable by the actuator. The plurality of wires extend from the circuit board of the base, through the needle and out of the slot.

CONTINUOUS GLUCOSE MONITORING DEVICE

NºPublicación:  EP4591791A2 30/07/2025
Solicitante: 
I SENS INC [KR]
i-Sens, Inc
EP_4591791_PA

Resumen de: EP4591791A2

The present disclosure relates to a continuous glucose monitoring device. The present disclosure provides a continuous glucose monitoring device wherein: a body attachment unit is manufactured in the state in which the body attachment unit is assembled in an applicator, and thus a user's additional work for attaching the body attachment unit to the body is minimized and the body attachment unit can be attached to the body by simply operating the applicator; in particular, a wireless communication chip is disposed in the body attachment unit so as to communicate with an external terminal, and thus simple and convenient use can be achieved without any additional work for connection of a separate transmitter and maintenance and management can also be easily performed; and the monitoring operation is started by the user's manipulation after the body attachment unit is attached to the body, and thus the user can adjust the operation start time to an appropriate point as necessary and the operation can be started in a stabilized state so as to enable more accurate glucose monitoring.

Real-time adjusting method for insulin infusion amount and closed-loop infusion system

NºPublicación:  CN120381580A 29/07/2025
Solicitante: 
SHENZHEN ARUI MEDICAL ELECTRONICS CO LTD
\u6DF1\u5733\u5E02\u963F\u745E\u533B\u7597\u7535\u5B50\u6709\u9650\u516C\u53F8
CN_120381580_PA

Resumen de: CN120381580A

The invention discloses a real-time adjusting method for insulin infusion volume, which adopts a closed-loop control method, and dynamically adjusts the infusion volume of an insulin pump based on a comparison result of a predicted blood glucose parameter and a preset blood glucose range through collected blood glucose data and predicted future blood glucose data, thereby realizing more accurate blood glucose control. The invention further discloses a closed-loop infusion system designed based on the real-time adjustment method. The closed-loop infusion system comprises a controller, a blood glucose detection system, an insulin pump and a continuous glucose monitoring system. Compared with open-loop control, the closed-loop control can monitor the blood glucose level of the patient in real time and automatically adjust the insulin infusion amount according to real-time data, and the high-automation system can more accurately maintain the blood glucose within the target range and reduce blood glucose fluctuation. Moreover, the closed-loop control system reduces the requirements of patients or medical staff for manually calculating and adjusting the insulin dosage, so that personal errors are reduced, automatic adjustment can better adapt to individual differences and dynamic changes of the patients, the burden of the patients on blood glucose monitoring and insulin dosage adjustment is reduced, and the safety and effectiveness of treatment are improved.

Multifunctional insulin pen storage box

NºPublicación:  CN120381573A 29/07/2025
Solicitante: 
SHANGHAI YANGZHI REHABILITATION HOSPITAL SHANGHAI SUNSHINE REHABILITATION CENTER
\u4E0A\u6D77\u5E02\u517B\u5FD7\u5EB7\u590D\u533B\u9662\uFF08\u4E0A\u6D77\u5E02\u9633\u5149\u5EB7\u590D\u4E2D\u5FC3\uFF09
CN_120381573_PA

Resumen de: CN120381573A

The invention discloses a multifunctional insulin pen storage box, and relates to the technical field of medical auxiliary instruments, and the storage box comprises a storage box, a sealing cover assembly, an insulin pen storage drawer, a needle dismounting assembly, a dirty needle storage drawer and a standby material storage area. A plurality of partition plates are arranged in the insulin pen storage drawer to realize classified storage; the needle dismounting assembly adopts the design of a threaded clamping arm, the needle can be rapidly dismounted, the dismounted dirty needle falls into a dirty needle storage drawer through a recovery opening of a separation plate, and pollution is avoided; and the spare material storage area is provided with spare needle heads and special alcohol cotton ball slots, so that the needle heads and the alcohol cotton balls are convenient to take. Through integrated design, the problems that an existing insulin pen storage box is single in function and tedious in operation are solved, integrated operation of insulin pen storage, needle dismounting, dirty needle recycling and standby material management is achieved, the working efficiency of medical workers is remarkably improved, meanwhile, the risk of cross contamination is reduced, and the safety of medical workers is improved. The method is suitable for hospitals, clinics and other medical scenes.

Multi-wavelength optical rotation angle and dynamic spectrum blood glucose noninvasive measurement method of polarization camera

NºPublicación:  CN120381265A 29/07/2025
Solicitante: 
TIANJIN UNIV
\u5929\u6D25\u5927\u5B66
CN_120381265_PA

Resumen de: CN120381265A

The invention discloses a multi-wavelength optical rotation angle and dynamic spectrum blood glucose noninvasive measurement method of a polarization camera, and relates to the technical field of polarized light and spectral analysis, and the method comprises the following steps: taking the polarization camera as a sensor, and greatly improving the precision of the optical rotation angle and the dynamic spectrum through a method of superposing all pixel points in a collected image; a dynamic optical rotation angle and a dynamic spectrum are obtained by utilizing the idea of a dynamic spectrum theory, so that the influence caused by factors such as individual difference and instability of a light source in a measurement process is reduced, and the signal-to-noise ratio of data is improved; the dynamic optical rotation angle and the dynamic spectrum are combined for modeling, the information amount related to human body blood sugar components in the model building process is increased through the method of combining the two optical characteristics, and the modeling accuracy is improved. According to the multi-wavelength optical rotation angle and dynamic spectrum blood glucose noninvasive measurement method adopting the polarization camera, the problems that an existing detection method is low in signal to noise ratio and low in accuracy are solved, and high-precision measurement of noninvasive blood glucose content is achieved.

Intelligent real-time blood detection system based on intravascular indwelling sensor

NºPublicación:  CN120381266A 29/07/2025
Solicitante: 
THE FIRST AFFILIATED HOSPITAL OF GUANGZHOU MEDICAL UNIV GUANGZHOU RESPIRATORY CENTER
\u5E7F\u5DDE\u533B\u79D1\u5927\u5B66\u9644\u5C5E\u7B2C\u4E00\u533B\u9662\uFF08\u5E7F\u5DDE\u547C\u5438\u4E2D\u5FC3\uFF09
CN_120381266_PA

Resumen de: CN120381266A

According to the intelligent real-time blood detection system based on the intravascular indwelling sensors, through an intravascular indwelling multi-sensor integrated system (electrochemical/optical coaxial layered design), continuous monitoring of one-time puncture for more than or equal to 7 days is achieved, in a clinical test, puncture within 7 days can be reduced from 28 times to 3 times, an improved Kalman filtering algorithm eliminates signal crosstalk, and the detection accuracy is improved. The D-S evidence theory is combined to dynamically fuse multi-modal data, so that the blood glucose detection MARD is reduced to 4.1%, the blood potassium error is less than 0.08 mM, and the motion artifact residual error is 1t; and 0.5%. A real-time data transmission and intelligent alarm system significantly improves clinical response efficiency, self-adaptively calibrates individual differences, and realizes high-precision long-acting monitoring.

Diabetic foot ulcer early warning system and method based on multi-mode physiological signal fusion

NºPublicación:  CN120388740A 29/07/2025
Solicitante: 
HANGZHOU BIOYEAR MEDICAL EQUIPMENT CO LTD
\u676D\u5DDE\u8D1D\u4EBF\u533B\u7597\u5668\u68B0\u6709\u9650\u516C\u53F8
CN_120388740_PA

Resumen de: CN120388740A

The invention relates to the technical field of medical health, in particular to a diabetic foot ulcer early warning system and method based on multi-modal physiological signal fusion. Daily health of a diabetic foot is monitored in real time through a multi-dimensional sensor assembly; the data preprocessing system collects and preprocesses data monitored by the multi-dimensional sensor in real time, and the communication system uploads data information processed by the data preprocessing system to the cloud platform. The personalized health assessment system assesses and predicts the data of the current diabetic foot in real time and provides a reasonable suggestion scheme. According to the system and the method, by integrating a multi-modal sensor and an innovative algorithm, the monitoring performance and the user experience are remarkably improved, multi-modal data fusion is achieved, the monitoring performance is remarkably improved, edge calculation optimization response speed and energy consumption support personalized adaptation are remarkably improved, and the accuracy and the real-time performance of illness state assessment are remarkably improved.

Diabetic foot diagnosis and treatment insole with variable hardness and in-situ sensing and preparation method

NºPublicación:  CN120381171A 29/07/2025
Solicitante: 
UNIV OF SCIENCE AND TECHNOLOGY OF CHINA
\u4E2D\u56FD\u79D1\u5B66\u6280\u672F\u5927\u5B66
CN_120381171_PA

Resumen de: CN120381171A

The invention discloses a diabetic foot diagnosis and treatment insole with variable hardness and in-situ sensing and a preparation method, and belongs to the technical field of medical auxiliary instruments, the diabetic foot diagnosis and treatment insole is of a three-layer structure and comprises a surface conductive sensing layer and a sensing unit formed by compounding a conductive material on the surface of an animal leather base material, and the sensing unit is used for monitoring plantar pressure signals; the middle functional layer is prepared by blending carbonyl iron powder and shear hardening rubber through a rubber mixing mill and has both the magnetorheological effect and the shear hardening effect; and the bottom magnetic field generation layer adopts a packaging structure formed by sewing or hot-pressing compounding of a flexible magnet and a fabric base material, and is used for applying a controllable magnetic field to the middle functional layer. An innovative diagnosis and treatment scheme is provided for the diabetic foot by combining the rigidity adjustable behavior of the magnetorheological material in a magnetic field, the rate-related mechanical properties shown by the magnetorheological material and the shear hardening rubber under different impact loads and the accurate pressure sensing behavior of the conductive material in the porous fabric and utilizing the multi-physical field coupling effect (magnetism-force-electricity) of the material.

Big data-based automatic dose recommendation method and device for insulin intravenous injection system, processor and storage medium thereof

NºPublicación:  CN120361354A 25/07/2025
Solicitante: 
SHANGHAI GELU INFORMATION TECH CO LTD
\u4E0A\u6D77\u9769\u9C81\u4FE1\u606F\u6280\u672F\u6709\u9650\u516C\u53F8
CN_120361354_A

Resumen de: CN120361354A

The invention relates to an automatic dose recommendation method for an insulin intravenous injection system based on a big data AI algorithm. The method comprises the steps that patient information is added into the insulin intravenous injection system; selecting an insulin treatment mode as intravenous injection, and setting intravenous treatment parameters; calculating the next blood glucose detection time and an insulin regulatory factor according to the currently collected blood glucose value of the patient; on the basis of the calculation result, according to a system big data AI recommended insulin dosage algorithm, modeling processing is carried out, the insulin recommended dosage (infusion speed) of the current patient is calculated, and the patient is guided to accept medication and related matters needing attention to be reminded; and circulating the steps until the blood sugar of the patient reaches the target range. The invention further relates to a corresponding device, a processor and a storage medium thereof. By adopting the method, the device, the processor and the storage medium, an individualized, accurate and dynamic insulin regulation and control strategy can be customized for a patient, and the method, the device, the processor and the storage medium have important significance.

Automatic blood glucose detection instrument

NºPublicación:  CN120360549A 25/07/2025
Solicitante: 
SHAOXING PEOPLES HOSPITAL
HANGZHOU XINJIU MEDICAL TECH CO LTD
\u7ECD\u5174\u5E02\u4EBA\u6C11\u533B\u9662,
\u676D\u5DDE\u6615\u4E45\u533B\u7597\u79D1\u6280\u6709\u9650\u516C\u53F8
CN_120360549_PA

Resumen de: CN120360549A

The invention discloses an automatic blood glucose detection instrument, and relates to the technical field of medical equipment, the automatic blood glucose detection instrument comprises an operation table and a blood glucose meter body, the side wall of the operation table is provided with a storage box, the two side walls of the blood glucose meter body are provided with loudspeakers, and the top of the blood glucose meter body is fixedly provided with a turnover mechanism; and a mounting cylinder is inserted into the top of the turnover mechanism. Through the arrangement of the abutting ball, the two spring columns, the two fixing rods, the measuring spring, the two abutting springs, a reset assembly and a fixing disc, the stretching length of the puncture needle is adjusted in a self-adaptive mode according to the skin thickness of a patient, multiple puncture tests are not needed, puncture wounds of the patient are reduced, the infection risk is reduced, operation is easy, convenient and rapid, and the device is worthy of popularization and has a wide application prospect. And through the arrangement of a one-way spring, two wedge-shaped blocks, a plurality of triangular grooves and an insertion column, the puncture of the puncture needle is not influenced when the insertion column is reset every time.

Noninvasive full-closed-loop artificial pancreas system

NºPublicación:  CN120361345A 25/07/2025
Solicitante: 
HUAZHONG UNIV OF SCIENCE AND TECHNOLOGY
\u534E\u4E2D\u79D1\u6280\u5927\u5B66
CN_120361345_PA

Resumen de: CN120361345A

The invention belongs to the field of medical instruments, and relates to a non-invasive full-closed-loop artificial pancreas system which comprises a glucose optical detection module, a signal processing and analyzing module and a double-channel injection module which are sequentially connected, and the glucose optical detection module is used for emitting laser to a to-be-detected object to excite and generate a Raman spectrum signal; the blood glucose value acquisition module is also used for acquiring an actual blood glucose value of the to-be-detected object according to the Raman spectrum signal and transmitting the actual blood glucose value to the signal processing and analyzing module; the signal processing and analyzing module is used for analyzing the blood glucose change trend in a future preset time period based on the actual blood glucose value so as to generate a blood glucose reference trajectory; the signal processing and analyzing module is further used for controlling two injection channels of the double-channel injection module to be opened according to the blood glucose reference track so as to inject corresponding medicine to the to-be-detected object. According to the application, the functions of noninvasive real-time detection of the blood glucose level and accurate quantitative infusion of the corresponding medicine so as to intelligently control the blood glucose level can be achieved.

Insulin sterile injection device for diabetic patient

NºPublicación:  CN120361356A 25/07/2025
Solicitante: 
NANJING UNIV OF CHINESE MEDICINE
\u5357\u4EAC\u4E2D\u533B\u836F\u5927\u5B66
CN_120361356_PA

Resumen de: CN120361356A

The invention discloses an insulin sterile injection device for diabetics in the field of insulin injection, which comprises two mounting frames, side brackets are arranged at the upper parts of the sides close to each other, and a middle bracket is arranged between the two side brackets; the left end and the right end of the middle support are connected with the corresponding side supports through height adjusting assemblies respectively, a moving seat capable of moving transversely is arranged on the middle support, an injection positioning mechanism capable of swinging front and back is arranged on the moving seat, and an injector is installed on the injection positioning mechanism. A plurality of transverse connecting belts are connected to the outer sides of the two mounting frames, the outward end of each connecting belt on the left side is fixed to the first fixing part, and the outward end of each connecting belt on the right side is fixed to the second fixing part. The sterile insulin injection device can achieve sterile insulin injection, and injection part infection caused by nonstandard operation is avoided.

Type 2 diabetes data processing method based on photoelectric volume pulse wave signals

NºPublicación:  CN120372552A 25/07/2025
Solicitante: 
JIANGSU UNIV OF TECHNOLOGY
\u6C5F\u82CF\u7406\u5DE5\u5B66\u9662
CN_120372552_PA

Resumen de: CN120372552A

The invention provides a type-2 diabetes data processing method based on photoelectric volume pulse wave signals, which comprises the following steps: S1, collecting original photoelectric volume pulse wave signal data, and carrying out normalization and denoising preprocessing on the data; s2, constructing a conditional Wasserstein generative adversarial network model; s3, inputting the diabetes tag as a conditional variable into the generator, and performing adversarial training by introducing a gradient penalty mechanism; s4, synthesizing PPG signal samples of a specified category by using the trained generator; s5, mixing the generated sample with a real sample, and constructing a data set with balanced category distribution; and S6, performing type 2 diabetes prediction analysis on the enhanced data by adopting a multi-classifier fusion framework. The invention provides an improved conditional Wasserstein generative adversarial network algorithm with gradient penalty aiming at the problems of limited number of PPG signal data samples and extremely unbalanced category distribution in type 2 diabetes mellitus prediction. And through high-quality synthetic sample generation and data enhancement, the data set scale is obviously expanded.

Real-time blood glucose monitor and high-precision blood glucose monitoring method thereof

NºPublicación:  CN120376185A 25/07/2025
Solicitante: 
GUANGANMEN HOSPITAL CHINA ACAD OF CHINESE MEDICAL SCIENCES
\u4E2D\u56FD\u4E2D\u533B\u79D1\u5B66\u9662\u5E7F\u5B89\u95E8\u533B\u9662
CN_120376185_PA

Resumen de: CN120376185A

The invention relates to the technical field of blood glucose monitoring, in particular to a real-time blood glucose monitor and a high-precision blood glucose monitoring method thereof. The method comprises the following steps: acquiring an analysis curve peak of a daytime period every day in a monitoring period, acquiring a normal diet period according to an overlapping degree of time intervals corresponding to the analysis curve peak in different days, and determining the normal diet period according to the overlapping condition of the time intervals corresponding to the analysis curve peak and the normal diet period. Selecting diet peaks in the analysis curve peaks according to morphological characteristics of different analysis curve peaks; and determining an abnormal index according to the peak value difference and morphological characteristic difference between the analysis curve peak and the diet peak, training a neural network according to the analysis curve peak and the abnormal index of each day except the current day in the monitoring period, and predicting the blood glucose condition in the night time period in the current day by using the trained neural network. According to the method, the attention condition of the analysis curve peak in the neural network process is adaptively set based on the abnormal indexes, and the monitoring precision of the blood sugar of the patient is improved.

Continuous detection glucometer for intensive care department

NºPublicación:  CN120369948A 25/07/2025
Solicitante: 
YANG YI
\u6768\u827A
CN_120369948_PA

Resumen de: CN120369948A

The invention belongs to the technical field of blood glucose detection, and particularly relates to a continuous detection blood glucose meter for the intensive care department, which comprises a transparent shell, the shell comprises an upper shell and two lower shells, the right parts of the lower shells are provided with finger grooves, the left part of the shell is provided with a blood glucose detector, and a translation rod driven by a driving mechanism is arranged below the blood glucose detector; and the right end of the translation rod is connected with a push block extending into the shell. A finger is placed in a finger groove, blood is taken through a blood taking needle, the finger is pressed through a pressing block, a translation rod, a pushing block and a moving block are controlled to move leftwards, a blood glucose detection plate with sucked blood is driven to be inserted into a blood glucose detector, and other blood glucose detection plates are limited through two pairs of limiting parts; and the translation rod, the push block and the moving blocks are controlled to move rightwards, the used blood glucose detection plate is taken out, then the translation rod and the push block are reset, the next moving block is embedded into the placement groove, automatic replacement of the blood glucose detection plate is completed, repeated blood glucose detection is continuously carried out, and the blood glucose detection efficiency is improved.

Insulin loading and unloading needle device

NºPublicación:  CN223143897U 25/07/2025
Solicitante: 
SHANGHAI YONGCHENG GIFT CO LTD
\u4E0A\u6D77\u6C38\u6F84\u793C\u54C1\u6709\u9650\u516C\u53F8
CN_223143897_U

Resumen de: CN223143897U

The utility model discloses an insulin loading and unloading needle device which comprises a sleeve, two through holes are symmetrically formed in the two side walls of the sleeve, an elastic pressing edge is installed in each through hole, a pressing head is installed on the lower portion of the outer wall of each elastic pressing edge, and a limiting head is installed on the lower portion in each elastic pressing edge. A through hole is formed in the middle of the inner bottom end of the sleeve, and four limiting tables are annularly distributed on the periphery of the inner bottom end of the sleeve. The insulin injection pen needle has the advantages that on one hand, the outer needle cap can be effectively limited under the action of the through hole, the elastic clamping edge, the pressing head and the limiting head, rapid separation of the insulin injection pen needle and the outer needle cap during installation is achieved, and on the other hand, the insulin injection pen needle can be shielded and protected during disassembly under the action of the sleeve; and the insulin injection pen needle head is prevented from accidentally injuring hospital personnel during disassembly, so that the safety during disassembly of the insulin injection pen needle head is better.

Insulin pump protection device

Nº publicación: CN223143876U 25/07/2025

Solicitante:

CHONGQING YONGCHUAN PEOPLES HOSPITAL
\u91CD\u5E86\u5E02\u6C38\u5DDD\u533A\u4EBA\u6C11\u533B\u9662

CN_223143876_U

Resumen de: CN223143876U

The utility model belongs to the technical field of insulin pumps, and particularly relates to an insulin pump protection device which comprises an insulin pump body. A fixing assembly is arranged on the side wall of the insulin pump body; the insulin pump body is connected with a protection box body through a fixing assembly. The insulin pump body is placed in the protection box body; the side wall of the protection box body is fixedly connected with an air bag strip. A plurality of groups of air bag strips are arranged on the side wall of the protection box body and are uniformly distributed at the edges of the protection box body; according to the step, through the arrangement of a protection box body, an air bag strip, an air bag ball, a first sponge block, a cover plate and a second sponge block, the insulin pump body is placed and fixed in the insulin pump body, the situation that the insulin pump body falls to cause damage to the insulin pump body is reduced, and the situation that the insulin pump body is damaged when extruded is reduced; the service life of the insulin pump body is prolonged, and the use safety of the device is improved.

traducir